BanColombia S.A. (NYSE:CIB - Get Free Report) reached a new 52-week high on Thursday . The company traded as high as $53.99 and last traded at $53.67, with a volume of 362479 shares changing hands. The stock had previously closed at $53.29.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on the company. UBS Group reiterated a "neutral" rating and issued a $38.00 price objective (up from $35.00) on shares of BanColombia in a research report on Monday, June 2nd. Bank of America restated an "underperform" rating on shares of BanColombia in a research note on Thursday, September 11th. Finally, Zacks Research downgraded BanColombia from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 26th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Reduce" and an average price target of $43.75.
Check Out Our Latest Stock Analysis on CIB
BanColombia Stock Performance
The stock has a market capitalization of $12.38 billion, a price-to-earnings ratio of 7.82, a P/E/G ratio of 1.03 and a beta of 0.96. The firm has a 50-day moving average of $47.69 and a 200-day moving average of $43.91. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 0.29.
BanColombia (NYSE:CIB - Get Free Report) last posted its earnings results on Thursday, August 7th. The bank reported $1.79 EPS for the quarter, topping the consensus estimate of $1.66 by $0.13. The firm had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.75 billion. BanColombia had a return on equity of 19.77% and a net margin of 15.30%. As a group, sell-side analysts predict that BanColombia S.A. will post 6 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Caitong International Asset Management Co. Ltd lifted its stake in BanColombia by 253.2% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 657 shares of the bank's stock worth $30,000 after purchasing an additional 471 shares in the last quarter. Tower Research Capital LLC TRC lifted its stake in BanColombia by 796.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 977 shares of the bank's stock worth $45,000 after purchasing an additional 868 shares in the last quarter. SVB Wealth LLC purchased a new position in BanColombia in the 1st quarter worth approximately $45,000. Corient Private Wealth LLC purchased a new position in BanColombia in the 2nd quarter worth approximately $205,000. Finally, West Family Investments Inc. purchased a new position in BanColombia in the 2nd quarter worth approximately $222,000.
About BanColombia
(
Get Free Report)
Bancolombia SA, together with its subsidiaries, provides banking products and services in Colombia and internationally. The company operates through nine segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking, and All Other.
Featured Stories
Before you consider Grupo Cibest, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grupo Cibest wasn't on the list.
While Grupo Cibest currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.